SPRINKLR INC-A (CXM) Stock Fundamental Analysis
NYSE:CXM - New York Stock Exchange, Inc. - US85208T1079 - Common Stock - Currency: USD
CXM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. Both the profitability and the financial health of CXM get a neutral evaluation. Nothing too spectacular is happening here. CXM is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
CXM had positive earnings in the past year.
In the past year CXM had a positive cash flow from operations.
In multiple years CXM reported negative net income over the last 5 years.
Of the past 5 years CXM 4 years had a positive operating cash flow.
1.2 Ratios
CXM has a Return On Assets of 9.20%. This is amongst the best in the industry. CXM outperforms 85.11% of its industry peers.
Looking at the Return On Equity, with a value of 17.10%, CXM belongs to the top of the industry, outperforming 84.40% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.36%, CXM is in the better half of the industry, outperforming 74.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.2% | ||
| ROE | 17.1% | ||
| ROIC | 4.36% |
ROA(3y)3.01%
ROA(5y)-1.91%
ROE(3y)5.76%
ROE(5y)-4.85%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of CXM (13.58%) is better than 80.14% of its industry peers.
Looking at the Operating Margin, with a value of 4.42%, CXM is in the better half of the industry, outperforming 71.63% of the companies in the same industry.
CXM has a Gross Margin of 71.05%. This is comparable to the rest of the industry: CXM outperforms 57.80% of its industry peers.
CXM's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.42% | ||
| PM (TTM) | 13.58% | ||
| GM | 71.05% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y3.08%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CXM is destroying value.
Compared to 1 year ago, CXM has less shares outstanding
Compared to 5 years ago, CXM has more shares outstanding
CXM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
CXM has an Altman-Z score of 2.96. This is not the best score and indicates that CXM is in the grey zone with still only limited risk for bankruptcy at the moment.
CXM has a Altman-Z score (2.96) which is in line with its industry peers.
CXM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 2.96 |
ROIC/WACC0.42
WACC10.34%
2.3 Liquidity
A Current Ratio of 1.74 indicates that CXM should not have too much problems paying its short term obligations.
The Current ratio of CXM (1.74) is comparable to the rest of the industry.
CXM has a Quick Ratio of 1.74. This is a normal value and indicates that CXM is financially healthy and should not expect problems in meeting its short term obligations.
CXM has a Quick ratio (1.74) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.74 |
3. Growth
3.1 Past
The earnings per share for CXM have decreased by -9.52% in the last year.
The Revenue has been growing slightly by 6.75% in the past year.
CXM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.68% yearly.
EPS 1Y (TTM)-9.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)6.75%
Revenue growth 3Y17.38%
Revenue growth 5Y19.68%
Sales Q2Q%4.87%
3.2 Future
The Earnings Per Share is expected to grow by 5.36% on average over the next years.
The Revenue is expected to grow by 8.62% on average over the next years. This is quite good.
EPS Next Y15.21%
EPS Next 2Y11.81%
EPS Next 3Y11.41%
EPS Next 5Y5.36%
Revenue Next Year3.98%
Revenue Next 2Y4.54%
Revenue Next 3Y5.52%
Revenue Next 5Y8.62%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 22.26 indicates a rather expensive valuation of CXM.
73.40% of the companies in the same industry are more expensive than CXM, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.54, CXM is valued at the same level.
CXM is valuated rather expensively with a Price/Forward Earnings ratio of 19.33.
CXM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CXM is cheaper than 75.53% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.28, CXM is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.26 | ||
| Fwd PE | 19.33 |
4.2 Price Multiples
78.01% of the companies in the same industry are more expensive than CXM, based on the Enterprise Value to EBITDA ratio.
CXM's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CXM is cheaper than 78.01% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.18 | ||
| EV/EBITDA | 24.23 |
4.3 Compensation for Growth
CXM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CXM has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.46
PEG (5Y)N/A
EPS Next 2Y11.81%
EPS Next 3Y11.41%
5. Dividend
5.1 Amount
CXM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
8.46
-0.57 (-6.31%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners79.44%
Inst Owner Change-0.53%
Ins Owners6.03%
Ins Owner Change44.64%
Market Cap2.19B
Analysts65.88
Price Target10.71 (26.6%)
Short Float %9%
Short Ratio4.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.14%
Min EPS beat(2)21.24%
Max EPS beat(2)39.04%
EPS beat(4)3
Avg EPS beat(4)17.48%
Min EPS beat(4)-14.78%
Max EPS beat(4)39.04%
EPS beat(8)7
Avg EPS beat(8)34.7%
EPS beat(12)11
Avg EPS beat(12)104.49%
EPS beat(16)15
Avg EPS beat(16)86.72%
Revenue beat(2)1
Avg Revenue beat(2)0.39%
Min Revenue beat(2)-0.02%
Max Revenue beat(2)0.8%
Revenue beat(4)3
Avg Revenue beat(4)0.58%
Min Revenue beat(4)-0.02%
Max Revenue beat(4)1.16%
Revenue beat(8)6
Avg Revenue beat(8)1.02%
Revenue beat(12)9
Avg Revenue beat(12)0.95%
Revenue beat(16)13
Avg Revenue beat(16)1.74%
PT rev (1m)8.25%
PT rev (3m)1.2%
EPS NQ rev (1m)0.03%
EPS NQ rev (3m)4.35%
EPS NY rev (1m)0.33%
EPS NY rev (3m)4.45%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)1.04%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.26 | ||
| Fwd PE | 19.33 | ||
| P/S | 2.72 | ||
| P/FCF | 21.18 | ||
| P/OCF | 18.3 | ||
| P/B | 3.42 | ||
| P/tB | 3.71 | ||
| EV/EBITDA | 24.23 |
EPS(TTM)0.38
EY4.49%
EPS(NY)0.44
Fwd EY5.17%
FCF(TTM)0.4
FCFY4.72%
OCF(TTM)0.46
OCFY5.46%
SpS3.11
BVpS2.47
TBVpS2.28
PEG (NY)1.46
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.2% | ||
| ROE | 17.1% | ||
| ROCE | 5.13% | ||
| ROIC | 4.36% | ||
| ROICexc | 24.79% | ||
| ROICexgc | 42.07% | ||
| OM | 4.42% | ||
| PM (TTM) | 13.58% | ||
| GM | 71.05% | ||
| FCFM | 12.83% |
ROA(3y)3.01%
ROA(5y)-1.91%
ROE(3y)5.76%
ROE(5y)-4.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y3.08%
F-Score7
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 86.2% | ||
| Cap/Sales | 2.02% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 219.67% | ||
| Profit Quality | 94.52% | ||
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.74 | ||
| Altman-Z | 2.96 |
F-Score7
WACC10.34%
ROIC/WACC0.42
Cap/Depr(3y)122.21%
Cap/Depr(5y)126.89%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y15.21%
EPS Next 2Y11.81%
EPS Next 3Y11.41%
EPS Next 5Y5.36%
Revenue 1Y (TTM)6.75%
Revenue growth 3Y17.38%
Revenue growth 5Y19.68%
Sales Q2Q%4.87%
Revenue Next Year3.98%
Revenue Next 2Y4.54%
Revenue Next 3Y5.52%
Revenue Next 5Y8.62%
EBIT growth 1Y-16.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year97.65%
EBIT Next 3Y38.13%
EBIT Next 5Y27.49%
FCF growth 1Y241.27%
FCF growth 3YN/A
FCF growth 5Y33.79%
OCF growth 1Y148.61%
OCF growth 3YN/A
OCF growth 5Y32.54%